1. Biomarkers of systemic inflammation predict survival in stage III non-small cell lung cancer treated with chemoradiotherapy. (March 2022) Authors: Langley, Benjamin; Leach, James; Fenner, Florence; Killean, Angus; Barrie, Colin; Maclennan, Kirsty; Campbell, Sorcha; Evans, Tamasin; Tufail, Aisha; Harrow, Stephen; McMenemy, Maria; MacKean, Melanie; Phillips, Iain; Stares, Mark Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gross tumour volume predicts survival and correlates with pre-treatment serum albumin concentration in patients with stage III non-small cell lung cancer treated with chemo-radiotherapy. (March 2022) Authors: Killean, Angus; Fenner, Florence; Stares, Mark; Evans, Tamasin; Maclennan, Kirsty; Tufail, Aisha; Campbell, Sorcha; Harrow, Stephen; McLaren, Duncan; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real-world outcomes for patients with inoperable stage III non-small cell lung cancer: a prognostic role for albumin?. (March 2022) Authors: Leach, James; Stares, Mark; Langley, Benjamin; Fenner, Florence; Killean, Angus; Barrie, Colin; Maclennan, Kirsty; Campbell, Sorcha; Evans, Tamasin; Tufail, Aisha; Harrow, Stephen; McMenemy, Maria; Mackean, Melanie; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗